(Q40803066)

23 September 2017

Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist (English)

1 reference

23 September 2017

0 references

multiple drug resistance

1 reference

5

1 reference

23 September 2017

Lovekamp T

1

1 reference

23 September 2017

Cooper PS

2

1 reference

23 September 2017

Hardison J

3

1 reference

23 September 2017

Bryant SD

4

1 reference

23 September 2017

Balboni G

6

1 reference

23 September 2017

Salvadori S

7

1 reference

23 September 2017

Lazarus LH

8

1 reference

23 September 2017

1 May 2001

1 reference

23 September 2017

1 reference

23 September 2017

902

1 reference

23 September 2017

1

1 reference

23 September 2017

131-134

1 reference

Opioid diketopiperazines: synthesis and activity of a prototypic class of opioid antagonists

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Dmt-Tic-OH a highly selective and potent delta-opioid dipeptide receptor antagonist after systemic administration in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline-3-carboxylic acid at position 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Blood-brain barrier restriction of peptides and the low uptake of enkephalins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Deltorphin transport across the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Circumvention of adriamycin resistance by dipyridamole analogues: a structure-activity relationship study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

Adamantane as a brain-directed drug carrier for poorly absorbed drug: antinociceptive effects of [D-Ala2]Leu-enkephalin derivatives conjugated with the 1-adamantane moiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902363-0

10.1016/S0006-8993(01)02363-0

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference